Sagittarius Life Science Corp

Chart & Performance

D1W1MN

P/E

—

P/S

4.90

EPS

—

Div Yield, %

—

Shrs. gr., 5y

10.56%

Rev. gr., 5y

-9.12%

Revenues

346m

-26.01%

Net income

-50m

L+2.13%

CFO

-36m

L-18.96%

Dividend

Aug 31, 20181.605 TWD/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

Sagittarius Life Science Corp, established in 1998 and headquartered in Taipei, Taiwan, focuses on the innovation, development, and sale of both traditional Chinese and modern Western pharmaceuticals, alongside nutritional supplements. Its market reach extends throughout Taiwan and the broader Asian region. Beyond its primary healthcare offerings, the company also provides a variety of organic food products, household essentials, and pet sustenance. A significant part of its activities includes pioneering advancements through biotechnology research and development initiatives.

URL

https://www.naturalbiokey.com/

IPO date

May 28, 2004

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title TWD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title TWD in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT